A Multi-Site Open-Label Extension Study of MDMA-Assisted Psychotherapy for PTSD
Clinical trial NCT04714359 · COMPLETED
Trial details
- NCT number
- NCT04714359
- Sponsor
- Resilient Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2023-11-01
- Enrollment
- 87
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.